SCHEMBL17034

SCHEMBL17034

CC(O)(c1cnc([C@]2(CN3C4COCC3C(O)C4)CN(S(=O)(=O)C3=CC=CCC3=S)CCN2)nc1)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 6/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16127 0.95 GCK (0.34) GCK
SCHEMBL17376 0.89 GCK (0.43) GCK
SCHEMBL16497 0.82 GCK (0.36) GCK
SCHEMBL21749 0.79 RORC (0.39) GCK
SCHEMBL16108 0.79 GCK (0.56) GCK
SCHEMBL12077939 0.79 GCK (0.56) GCK
SCHEMBL12078418 0.79 GCK (0.56) GCK
SCHEMBL12079355 0.79 GCK (0.56) GCK
SCHEMBL12078156 0.79 GCK (0.56) GCK
SCHEMBL17506 0.78 GCK (0.34) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed